Carregant...
Practical Considerations for Integrating Biosimilars Into Clinical Practice
The development of innovator biologics and now their biosimilars has created some unique challenges in oncology practice. The oncology advanced practitioner (OAP) must understand the key differences between the innovator biologic and biosimilars in regard to efficacy, safety, and immunogenicity. In...
Guardat en:
| Publicat a: | J Adv Pract Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Harborside Press LLC
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8163250/ https://ncbi.nlm.nih.gov/pubmed/34123479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2021.12.4.7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|